Trends and treatment outcomes of TB among people living with HIV: a nationwide cohort study, 2011–2022
The International Journal of Tuberculosis and Lung Disease · 2026
DOI: 10.5588/ijtld.25.0756 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2026. Verfasst von C Chung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym U…. Hauptthemen laut MEDLINE: HIV Infections, Antitubercular Agents, Tuberculosis, Coinfection.
Abstract (Originalsprache)
BACKGROUND
Recent trends and treatment outcomes of TB among people living with HIV (PLHIV) have been understudied in Korea.
METHODS
Using the nationwide K-TB-N cohort, we identified individuals with TB registered between 2011 and 2022. Among 373,812 TB cases, 931 had TB–HIV co-infection. TB treatment outcomes were compared between PLHIV and the general population using propensity score matching. Multivariable Cox proportional hazards models, including stratified and sensitivity analyses, were used to identify factors associated with death during TB treatment among PLHIV.
RESULTS
Most of TB–HIV patients were males (91.9%), under 60 years old (82.1%), and approximately 90% received antiretroviral therapy (ART). The number of TB–HIV cases declined from 120 in 2011 to 35 in 2022. Lost to follow-up and not evaluated outcomes decreased over time, whereas mortality remained stable at 10%–20%. The overall TB treatment success rate was 76.9% and mortality was higher than general population. Mortality was associated with older age and comorbidity burden, whereas ART showed a protective association only when initiated before TB diagnosis.
CONCLUSION
TB incidence among PLHIV in South Korea has declined over the past decade, but mortality during TB treatment remains high, driven largely by host-related factors including age and comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
- Department of Internal Medicine, MetroWest Medical Center, Framingham, MA, USA.
- Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Preventive Medicine, Seoul National University, Seoul, South Korea.
- School of Health Policy and Management, College of Health Science, Korea University, Seoul, South Korea.
- Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul, South Korea;, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yons…
Zitieren
APA
Chung, C., Choi, W., Lee, S. W., Jeong, D., Choi, H., Sohn, H., & Kang, Y. A. (2026). Trends and treatment outcomes of TB among people living with HIV: a nationwide cohort study, 2011–2022. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.25.0756
Vancouver
Chung C, Choi W, Lee SW, Jeong D, Choi H, Sohn H, et al. Trends and treatment outcomes of TB among people living with HIV: a nationwide cohort study, 2011–2022. The International Journal of Tuberculosis and Lung Disease. 2026. doi:10.5588/ijtld.25.0756
BibTeX
@article{Chung2026,
author = {Chung, C and Choi, W and Lee, S W and Jeong, D and Choi, H and Sohn, H and Kang, Y A},
title = {Trends and treatment outcomes of TB among people living with HIV: a nationwide cohort study, 2011–2022},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2026},
doi = {10.5588/ijtld.25.0756}
}
EUVIMED